ID - 771
HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH TRANSPLANT-INELIGIBLE OR TRANSPLANT-DEFERRED NEWLY DIAGNOSED MULTIPLE MYELOMA (MM) IN THE PHASE 3 CEPHEUS TRIAL
V Hungriaa, SZ Usmanib, T Faconc, S Zweegmand, N Bahalise, M Braunsteinf, L Pourg, J Martih, S Basui, A Maiolinoj
a Clínica Médica São Germano, São Paulo, Brazil
b Memorial Sloan Kettering Cancer Center, New York, United States
c University of Lille, Lille, France
d Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam, Netherlands
e Arnie Charbonneau Cancer Research Institute, University of Calgary, Calgary, Canada
f Perlmutter Cancer Center, NYU Langone Health, New York, United States
g University Hospital Brno, Brno, Czech Republic
h Hospital Universitario Mútua de Terrassa, Spain
i Royal Wolverhampton NHS Trust and University of Wolverhampton, United Kingdom
j Instituto Americas de Ensino, Pesquisa e Inovação, Rio de Janeiro, Brazil
Ver más
